{"id":246437,"date":"2026-09-15T12:52:19","date_gmt":"2026-09-15T07:22:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=246437"},"modified":"2026-09-15T12:52:22","modified_gmt":"2026-09-15T07:22:22","slug":"mangalam-drugs-and-organics-share-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-bull-case-vs-bear-case-2026\/","title":{"rendered":"Mangalam Drugs And Organics Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n

Mangalam Drugs And Organics CMP Rs 34.33 on 15 Sep 2026. 52W High Rs 79.49, Low Rs 22.80. PE not meaningful (loss making) vs sector 37.96. RSI 54.90.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Mangalam Drugs And Organics bull case for 2026 points toward the stock retesting its 52 week high of Rs 79.49, built on the strengths discussed below. The Mangalam Drugs And Organics bear case points toward a slide back near its 52 week low of Rs 22.80 if the risks play out instead. The stock currently trades at Rs 34.33, with a loss making bottom line, so the industry average PE of 37.96 is the reference point for any future re-rating. The next two quarters of earnings and sector data will likely decide which case plays out.<\/p>\n<\/div>\n

The Mangalam Drugs And Organics bull case is under the spotlight as investors weigh Mangalam Drugs And Organics’ recent price action against its underlying fundamentals. The stock trades at Rs 34.33, against a 52 week high of Rs 79.49 and a 52 week low of Rs 22.80, leaving room for both the Mangalam Drugs And Organics bull case and the Mangalam Drugs And Organics bear case to find support in the data.<\/p>\n

Mangalam Drugs And Organics operates in the Pharmaceutical and Specialty Chemicals Manufacturing space, and its return on equity of -43.08 percent and debt to equity ratio of 1.02 form the backbone of the fundamental picture. This article lays out the full Mangalam Drugs And Organics bull case and bear case, the data behind each scenario, and the catalysts that could tip the balance one way or the other.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n